Yifan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 905.92 million compared to CNY 1,200.34 million a year ago. Revenue was CNY 905.92 million compared to CNY 1,200.34 million a year ago. Net income was CNY 121.27 million compared to CNY 132.24 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.11 a year ago. Diluted earnings per share from continuing operations was CNY 0.1 compared to CNY 0.11 a year ago.